Methylene blue
Methylene blue (ProvayBlue): approved for acquired methemoglobinemia, its serotonin syndrome boxed warning, G6PD risk and unproven wellness claims.
FDA-approved injection, narrow use · Evidence grade B · Reviewed
- FDA-approvedMethemoglobinemiaProvayBlue injection
- Not approvedEnergy and memoryNot approved; lab and animal data
Methylene blue (ProvayBlue, MB). Dye and antidote.
BFDA-approved injection, narrow use. Evidence grade B: human trials, narrow or pending approval.
What is Methylene blue?
Methylene blue is a blue dye that also works as an antidote. It is given by IV for methemoglobinemia, a blood disorder in which red cells cannot carry oxygen well. It is promoted online as an oral wellness and brain supplement.
Is Methylene blue FDA-approved?
ProvayBlue injection was approved in 2016 to treat acquired methemoglobinemia in adults and children. In 2011 FDA warned that methylene blue can cause serious nervous system reactions in people taking serotonergic psychiatric drugs, and in 2024 the boxed warning was expanded to include opioids. FDA has not approved methylene blue for energy, mood, memory or anti-aging.
What does the evidence show for Methylene blue?
Approval relied on published case series, not randomized trials. Claims for energy, memory and aging rest mostly on lab and animal studies.
What are the known risks of Methylene blue?
The label carries a boxed warning: methylene blue may cause serious or fatal serotonin syndrome when combined with serotonergic drugs, such as SSRIs and SNRIs, and with opioids. It must not be used by people with G6PD deficiency, in whom it can cause severe red cell breakdown and anemia, or by people with severe allergy to it. Methylene blue is not on the 2026 WADA Prohibited List.
How is Methylene blue measured?
The approved product is an IV injection given in hospital. Nothing here needs calculating. Products sold online as "research use only" have no assurance of identity, dose or sterility. The calculator can do the arithmetic for any vial, but it cannot tell you what is actually in one.
Sources: FDA label: ProvayBlue (methylene blue) injection, 2024; FDA review: ProvayBlue approval summary (2016); FDA review: ProvayBlue label update (2024); Xue et al., methylene blue as an anti-aging drug, review (2021); WADA: 2026 Prohibited List. This profile does not recommend any dose or use.
For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.
Keep reading
Spot a mistake or an out-of-date fact? Report an error. We check every report against the sources.